PMID: 3549324Jan 1, 1987Paper

Genetic variation in the human hepatic cytochrome P-450 system

European Journal of Clinical Pharmacology
W Kalow


Studies in rodents indicate that the cytochrome P-450 system consists of a superfamily of heme proteins, produced by clusters of structural genes on different chromosomes. Equivalent P-450s of different species show more homologies than members of different P-450 families within a species. The Ah receptor serves the induction of members of one of the cytochrome families. The human structural gene for the methylcholanthrene-inducible P1-450 is located on Chromosome 15. This gene has been completely sequenced. The human Ah receptor is also measurable. New methods to measure inducibility in man involve new lymphocyte bioassays and mRNA determinations, while in vivo biotransformation studies of caffeine allow estimates of the state of induction. Structural genes for phenobarbital-inducible cytochromes have been localized to Chromosome 19. The deficiency of biotransformation of debrisoquine and sparteine continues to be explored intensely. Linkage studies indicate the gene for the variable cytochrome P-450 to be located on Chromosome 22. The deficiency is more likely due to structural variation than absence of the cytochrome. Inhibiting drugs can mimic the genetic defect. Many pharmacological and toxicological consequences of the de...Continue Reading


Jan 1, 1979·Diabetes·J Scott, P L Poffenbarger
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M S LennardH F Woods
Oct 1, 1985·Annals of Human Genetics·I R PhillipsJ Cowell
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C B McAllisterG R Wilkinson
Apr 1, 1987·British Journal of Clinical Pharmacology·M EichelbaumC Rittner
Jan 1, 1986·CRC Critical Reviews in Biochemistry·M Adesnik, M Atchison
Apr 1, 1986·Clinical Biochemistry·A B OkeyM S Denison
Apr 1, 1986·Clinical Biochemistry·W Kalow
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·J P Whitlock
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·F P GuengerichM V Martin
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·W Kalow
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·E S Vesell
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A KüpferG Pfaff
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M EichelbaumC Zekorn
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B J GouldD V Parke
Jul 1, 1986·British Journal of Clinical Pharmacology·M EichelbaumC Zekorn
Dec 1, 1986·Archives of Biochemistry and Biophysics·P R Ortiz de Montellano, A K Costa
Apr 1, 1985·British Journal of Clinical Pharmacology·M JurimaW Kalow
Nov 15, 1985·Klinische Wochenschrift·C ZekornM Eichelbaum
Nov 1, 1985·Acta Pharmacologica Et Toxicologica·K BrøsenL F Gram
Nov 1, 1973·The New England Journal of Medicine·G KellermannM Luyten-Kellerman
Jan 15, 1966·American Journal of Obstetrics and Gynecology·B W NewtonC C McCorriston
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·H L GurtooS K Bansal
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R H TukeyD W Nebert
Jul 1, 1984·Drugs·A C Asmal, A Marble
Oct 1, 1984·British Journal of Clinical Pharmacology·S C MitchellR L Smith
Jul 1, 1984·Canadian Journal of Physiology and Pharmacology·T InabaW Kalow
Nov 15, 1984·Biochemical Pharmacology·C H KleinbloesemD D Breimer
Jan 1, 1982·Drug Metabolism Reviews·J R Gillette
Jun 1, 1983·Therapeutic Drug Monitoring·F A de WolffD D Breimer
Jan 1, 1981·Pharmacology & Therapeutics·J B SchenkmanD L Cinti

❮ Previous
Next ❯


Feb 1, 1992·Journal of Clinical Pharmacology·R J Guttendorf, P J Wedlund
Jan 1, 1989·European Journal of Clinical Pharmacology·M HildebrandA Reichenberger
Jan 1, 1990·European Journal of Clinical Pharmacology·J KallioK Pyykkö
Feb 18, 2003·European Journal of Drug Metabolism and Pharmacokinetics·J WojcickiM Wojcicki
Feb 1, 1990·Journal of Steroid Biochemistry·S MaddenM L Orme
Jan 1, 1989·Pharmacology & Therapeutics·M S Lennard
Jan 1, 1990·Pharmacology & Therapeutics·D E Ryan, W Levin
Jan 1, 1990·Pharmacology & Therapeutics·A B Okey
Dec 1, 1993·Pharmacology & Therapeutics·M J Seaton, E S Vesell
Apr 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E SpinaE Perucca
Mar 29, 2000·Critical Reviews in Oncology/hematology·T De PasF de Braud
Dec 1, 1991·British Journal of Addiction·E M SellersU E Busto
Nov 1, 1988·Clinical and Experimental Pharmacology & Physiology·E J LeeG N Hee
Jan 1, 1993·Fundamental & Clinical Pharmacology·E J SereeY A Barra
Aug 1, 1990·Pharmacology & Toxicology·S Loft, H E Poulsen
Oct 1, 1990·Pharmacology & Toxicology·M S Lennard
Feb 1, 1995·Occupational and Environmental Medicine·W HalperinK Wille
Dec 1, 1988·The Journal of Clinical Investigation·N H Shear, S P Spielberg
Nov 1, 1992·Environmental Health Perspectives·T SugimuraK Wakabayashi
Jun 1, 1996·The Australian and New Zealand Journal of Psychiatry·S A Chong, H L Choo
Jun 1, 1990·Annals of Medicine·J BenítezF González-Rozas
Aug 1, 1989·Journal of Clinical Pharmacology·J van HartenD D Breimer
Dec 1, 1987·British Journal of Clinical Pharmacology·P A PhilipH J Rogers
May 1, 1989·British Journal of Clinical Pharmacology·J van HartenD D Breimer
Dec 1, 1988·British Journal of Clinical Pharmacology·J KallioE Iisalo
Apr 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·F BerthouA Guillouzo
Feb 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G MuralidharanT Inaba
Nov 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B K Park, N R Kitteringham
Dec 1, 1998·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
Jan 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M S Lennard
Jan 1, 1995·Clinical Pharmacology and Therapeutics·C M MasimirembwaW Kalow

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.